| For: | Tepsiri N, Chaturat L, Sripa B, Namwat W, Wongkham S, Bhudhisawasdi V, Tassaneeyakul W. Drug sensitivity and drug resistance profiles of human intrahepatic cholangiocarcinoma cell lines. World J Gastroenterol 2005; 11(18): 2748-2753 [PMID: 15884115 DOI: 10.3748/wjg.v11.i18.2748] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v11/i18/2748.htm |
| Number | Citing Articles |
| 1 |
LILI QIAO, NING LIANG, JIAN XIE, HUI LUO, JINGXIN ZHANG, GUODONG DENG, YUPENG LI, JIANDONG ZHANG. Gene silencing of galectin-3 changes the biological behavior of Eca109 human esophageal cancer cells. Molecular Medicine Reports 2016; 13(1) doi: 10.3892/mmr.2015.4543
|
| 2 |
Jose J. G. Marin, Elisa Herraez, Elisa Lozano, Rocio I. R. Macias, Oscar Briz. Models for Understanding Resistance to Chemotherapy in Liver Cancer. Cancers 2019; 11(11) doi: 10.3390/cancers11111677
|
| 3 |
WENJIE ZHOU, XIAOXUN CHEN, KE HE, JINFENG XIAO, XIAOPENG DUAN, RUI HUANG, ZHENGLIN XIA, JINGLIANG HE, JINQIAN ZHANG, GUOAN XIANG. Histone deacetylase inhibitor screening identifies HC toxin as the most effective in intrahepatic cholangiocarcinoma cells. Oncology Reports 2016; 35(5) doi: 10.3892/or.2016.4636
|
| 4 |
Benchamart Moolmuang, Mathuros Ruchirawat. The antiproliferative effects of ataxia-telangiectasia mutated and ATM- and Rad3-related inhibitions and their enhancements with the cytotoxicity of DNA damaging agents in cholangiocarcinoma cells. Journal of Pharmacy and Pharmacology 2021; 73(1) doi: 10.1093/jpp/rgaa050
|
| 5 |
Ornanong Tusskorn, Tueanjai Khunluck, Auemduan Prawan, Laddawan Senggunprai, Veerapol Kukongviriyapan. Mitochondrial division inhibitor-1 potentiates cisplatin-induced apoptosis via the mitochondrial death pathway in cholangiocarcinoma cells. Biomedicine & Pharmacotherapy 2019; 111 doi: 10.1016/j.biopha.2018.12.051
|
| 6 |
Samuel C. Fehling, Aubrey L. Miller, Patrick L. Garcia, Rebecca B. Vance, Karina J. Yoon. The combination of BET and PARP inhibitors is synergistic in models of cholangiocarcinoma. Cancer Letters 2020; 468 doi: 10.1016/j.canlet.2019.10.011
|
| 7 |
Jesus M. Banales, Jose J. G. Marin, Angela Lamarca, Pedro M. Rodrigues, Shahid A. Khan, Lewis R. Roberts, Vincenzo Cardinale, Guido Carpino, Jesper B. Andersen, Chiara Braconi, Diego F. Calvisi, Maria J. Perugorria, Luca Fabris, Luke Boulter, Rocio I. R. Macias, Eugenio Gaudio, Domenico Alvaro, Sergio A. Gradilone, Mario Strazzabosco, Marco Marzioni, Cédric Coulouarn, Laura Fouassier, Chiara Raggi, Pietro Invernizzi, Joachim C. Mertens, Anja Moncsek, Sumera I. Ilyas, Julie Heimbach, Bas Groot Koerkamp, Jordi Bruix, Alejandro Forner, John Bridgewater, Juan W. Valle, Gregory J. Gores. Cholangiocarcinoma 2020: the next horizon in mechanisms and management. Nature Reviews Gastroenterology & Hepatology 2020; 17(9) doi: 10.1038/s41575-020-0310-z
|
| 8 |
ARUNEE HEMATULIN, DANIEL SAGAN, KANLAYANEE SAWANYAWISUTH, WUNCHANA SEUBWAI, SOPIT WONGKHAM. Association between cellular radiosensitivity and G1/G2 checkpoint proficiencies in human cholangiocarcinoma cell lines. International Journal of Oncology 2014; 45(3) doi: 10.3892/ijo.2014.2520
|
| 9 |
Yaqing Chen, Dan Liu, Pengfei Liu, Yajing Chen, Huiling Yu, Quan Zhang. Identification of biomarkers of intrahepatic cholangiocarcinoma via integrated analysis of mRNA and miRNA microarray data. Molecular Medicine Reports 2017; 15(3) doi: 10.3892/mmr.2017.6123
|
| 10 |
Nathakan Klinhom-on, Wunchana Seubwai, Kanlayanee Sawanyawisuth, Sumalee Obchoei, Panupong Mahalapbutr, Sopit Wongkham. FOXM1 inhibitor, Siomycin A, synergizes and restores 5-FU cytotoxicity in human cholangiocarcinoma cell lines via targeting thymidylate synthase. Life Sciences 2021; 286 doi: 10.1016/j.lfs.2021.120072
|
| 11 |
Jose J.G. Marin, Rocio I.R. Macias, Maria J. Monte, Elisa Herraez, Ana Peleteiro-Vigil, Beatriz Sanchez de Blas, Paula Sanchon-Sanchez, Alvaro G. Temprano, Ricardo A. Espinosa-Escudero, Elisa Lozano, Oscar Briz, Marta R. Romero. Cellular Mechanisms Accounting for the Refractoriness of Colorectal Carcinoma to Pharmacological Treatment. Cancers 2020; 12(9) doi: 10.3390/cancers12092605
|
| 12 |
Nunghathai Sawasdee, Kanyaluck Jantakee, Methi Wathikthinnakon, Suthida Panwong, Jeeraporn Pekkoh, Kritsana Duangjan, Pa-thai Yenchitsomanus, Aussara Panya. Microalga Chlorella sp. extract induced apoptotic cell death of cholangiocarcinoma via AKT/mTOR signaling pathway. Biomedicine & Pharmacotherapy 2023; 160 doi: 10.1016/j.biopha.2023.114306
|
| 13 |
Wiratchanee Mahavorasirikul, Vithoon Viyanant, Wanna Chaijaroenkul, Arunporn Itharat, Kesara Na-Bangchang. Cytotoxic activity of Thai medicinal plants against human cholangiocarcinoma, laryngeal and hepatocarcinoma cells in vitro
. BMC Complementary and Alternative Medicine 2010; 10(1) doi: 10.1186/1472-6882-10-55
|
| 14 |
Xinsheng Gu, Jose E. Manautou. Regulation of hepatic ABCC transporters by xenobiotics and in disease states. Drug Metabolism Reviews 2010; 42(3) doi: 10.3109/03602531003654915
|
| 15 |
Nunghathai Sawasdee, Chutamas Thepmalee, Jatuporn Sujjitjoon, Petlada Yongpitakwattana, Mutita Junking, Naravat Poungvarin, Pa-thai Yenchitsomanus, Aussara Panya. Gemcitabine enhances cytotoxic activity of effector T-lymphocytes against chemo-resistant cholangiocarcinoma cells. International Immunopharmacology 2020; 78 doi: 10.1016/j.intimp.2019.106006
|
| 16 |
Kitti Intuyod, Aroonsri Priprem, Chawalit Pairojkul, Chariya Hahnvajanawong, Kulthida Vaeteewoottacharn, Porntip Pinlaor, Somchai Pinlaor. Anthocyanin complex exerts anti-cholangiocarcinoma activities and improves the efficacy of drug treatment in a gemcitabine-resistant cell line. International Journal of Oncology 2018; doi: 10.3892/ijo.2018.4306
|
| 17 |
N Kunkeaw, S H Jeon, K Lee, B H Johnson, S Tanasanvimon, M Javle, C Pairojkul, Y Chamgramol, W Wongfieng, B Gong, C Leelayuwat, Y S Lee. Cell death/proliferation roles for nc886, a non-coding RNA, in the protein kinase R pathway in cholangiocarcinoma. Oncogene 2013; 32(32) doi: 10.1038/onc.2012.382
|
| 18 |
Kahori Seto, Junichi Shoda, Tomohisa Horibe, Eiji Warabi, Masayuki Kohno, Toru Yanagawa, Hiroki Bukawa, Yasuni Nakanuma, Koji Kawakami. Targeting Interleukin-4 Receptor Alpha by Hybrid Peptide for Novel Biliary Tract Cancer Therapy. International Journal of Hepatology 2014; 2014 doi: 10.1155/2014/584650
|
| 19 |
Qingfan Zheng, Bin Zhang, Changfeng Li, Xuewen Zhang. Overcome Drug Resistance in Cholangiocarcinoma: New Insight Into Mechanisms and Refining the Preclinical Experiment Models. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.850732
|
| 20 |
Michael J. Smout, Javier Sotillo, Thewarach Laha, Atiroch Papatpremsiri, Gabriel Rinaldi, Rafael N. Pimenta, Lai Yue Chan, Michael S. Johnson, Lynne Turnbull, Cynthia B. Whitchurch, Paul R. Giacomin, Corey S. Moran, Jonathan Golledge, Norelle Daly, Banchob Sripa, Jason P. Mulvenna, Paul J. Brindley, Alex Loukas, P'ng Loke. Carcinogenic Parasite Secretes Growth Factor That Accelerates Wound Healing and Potentially Promotes Neoplasia. PLOS Pathogens 2015; 11(10) doi: 10.1371/journal.ppat.1005209
|
| 21 |
Somkid Janeklang, Archawin Nakaew, Kulthida Vaeteewoottacharn, Wunchana Seubwai, Patcharee Boonsiri, Gorkem Kismali, Apichart Suksamrarn, Seiji Okada, Sopit Wongkham. In vitro and In vivo Antitumor Activity of Tiliacorinine in Human Cholangiocarcinoma. Asian Pacific Journal of Cancer Prevention 2014; 15(17) doi: 10.7314/APJCP.2014.15.17.7473
|
| 22 |
YUE GU, LINFENG XIAO, YANLIN MING, ZHIZHONG ZHENG, WENGANG LI. Corilagin suppresses cholangiocarcinoma progression through Notch signaling pathway in vitro and in vivo. International Journal of Oncology 2016; 48(5) doi: 10.3892/ijo.2016.3413
|
| 23 |
Jose J.G. Marin, Rocio I.R. Macias, Elisa Herraez, Elisa Lozano, Marta R. Romero, Silvia Di Giacomo, Thomas Efferth, Oscar Briz. Drug Efflux Pumps in Cancer Resistance Pathways: From Molecular Recognition and Characterization to Possible Inhibition Strategies in Chemotherapy. 2020; doi: 10.1016/B978-0-12-816434-1.00007-3
|
| 24 |
Elisa Lozano, Maitane Asensio, Laura Perez‐Silva, Jesus M. Banales, Oscar Briz, Jose J.G. Marin. MRP3‐Mediated Chemoresistance in Cholangiocarcinoma: Target for Chemosensitization Through Restoring SOX17 Expression. Hepatology 2020; 72(3) doi: 10.1002/hep.31088
|
| 25 |
Christian Mayr, Tobias Kiesslich, Dominik Paul Modest, Sebastian Stintzing, Matthias Ocker, Daniel Neureiter. Chemoresistance and resistance to targeted therapies in biliary tract cancer: what have we learned?. Expert Opinion on Investigational Drugs 2022; 31(2) doi: 10.1080/13543784.2022.2034785
|
| 26 |
S. Rau, F. Autschbach, H. D. Riedel, J. Konig, H. Kulaksiz, A. Stiehl, J. F. Riemann, D. Rost. Expression of the multidrug resistance proteins MRP2 and MRP3 in human cholangiocellular carcinomas. European Journal of Clinical Investigation 2008; 38(2) doi: 10.1111/j.1365-2362.2007.01916.x
|
| 27 |
David K. Lau, Dmitri Mouradov, Wiphawan Wasenang, Ian Y. Luk, Cameron M. Scott, David S. Williams, Yvonne H. Yeung, Temduang Limpaiboon, George F. Iatropoulos, Laura J. Jenkins, Camilla M. Reehorst, Fiona Chionh, Mehrdad Nikfarjam, Daniel Croagh, Amardeep S. Dhillon, Andrew J. Weickhardt, Toshihide Muramatsu, Yoshimasa Saito, Niall C. Tebbutt, Oliver M. Sieber, John M. Mariadason. Genomic Profiling of Biliary Tract Cancer Cell Lines Reveals Molecular Subtypes and Actionable Drug Targets. iScience 2019; 21 doi: 10.1016/j.isci.2019.10.044
|
| 28 |
Inthuon Kulma, Kesara Na-Bangchang, Andrea Carvallo Herrera, Ifeanyi Theodora Ndubuisi, Masashi Iwasaki, Hiromi Tomono, Craig T. Morita, Haruki Okamura, Hiroshi Mukae, Yoshimasa Tanaka. Analysis of the Effector Functions of Vδ2 γδ T Cells and NK Cells against Cholangiocarcinoma Cells. Cells 2024; 13(16) doi: 10.3390/cells13161322
|
| 29 |
WAREEPORN WATTANAWONGDON, CHARIYA HAHNVAJANAWONG, NISANA NAMWAT, SIRIMAS KANCHANAWAT, THIDARUT BOONMARS, PATCHAREE JEARANAIKOON, CHANWIT LEELAYUWAT, ANCHALEE TECHASEN, WUNCHANA SEUBWAI. Establishment and characterization of gemcitabine-resistant human cholangiocarcinoma cell lines with multidrug resistance and enhanced invasiveness. International Journal of Oncology 2015; 47(1) doi: 10.3892/ijo.2015.3019
|
| 30 |
Chutipa Chiawpanit, Suthida Panwong, Nunghathai Sawasdee, Pa-thai Yenchitsomanus, Aussara Panya. Genistein Sensitizes Human Cholangiocarcinoma Cell Lines to Be Susceptible to Natural Killer Cells. Biology 2022; 11(8) doi: 10.3390/biology11081098
|
| 31 |
Kornkamon Lertsuwan, Supathra Phoaubon, Nathapol Tasnawijitwong, Jomnarong Lertsuwan. Adenosine Suppresses Cholangiocarcinoma Cell Growth and Invasion in Equilibrative Nucleoside Transporters-Dependent Pathway. International Journal of Molecular Sciences 2020; 21(3) doi: 10.3390/ijms21030814
|
| 32 |
Jeerati Prompipak, Thanaset Senawong, Banchob Sripa, Albert J. Ketterman, Suppawit Utaiwat, Khanutsanan Woranam, Jarckrit Jeeunngoi, Gulsiri Senawong. Anticancer effects of the combined Thai noni juice ethanolic extracts and 5-fluorouracil against cholangiocarcinoma cells in vitro and in vivo. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-94049-z
|
| 33 |
Jose J.G. Marin, Elisa Lozano, Elisa Herraez, Maitane Asensio, Silvia Di Giacomo, Marta R. Romero, Oscar Briz, Maria A. Serrano, Thomas Efferth, Rocio I.R. Macias. Chemoresistance and chemosensitization in cholangiocarcinoma. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2018; 1864(4) doi: 10.1016/j.bbadis.2017.06.005
|
| 34 |
Ana F. Brito, Ana M. Abrantes, João C. Encarnação, José G. Tralhão, Maria F. Botelho. Cholangiocarcinoma: from molecular biology to treatment. Medical Oncology 2015; 32(11) doi: 10.1007/s12032-015-0692-x
|
| 35 |
Jose J.G. Marin, Rocio I.R. Macias, Candela Cives-Losada, Ana Peleteiro-Vigil, Elisa Herraez, Elisa Lozano. Plasma Membrane Transporters as Biomarkers and Molecular Targets in Cholangiocarcinoma. Cells 2020; 9(2) doi: 10.3390/cells9020498
|
| 36 |
Katsuaki Ura, Kazutaka Obama, Seiji Satoh, Yoshiharu Sakai, Yusuke Nakamura, Yoichi Furukawa. Enhanced RASGEF1A Expression Is Involved in the Growth and Migration of Intrahepatic Cholangiocarcinoma. Clinical Cancer Research 2006; 12(22) doi: 10.1158/1078-0432.CCR-06-0783
|
| 37 |
Jeerati Prompipak, Thanaset Senawong, Banchob Sripa, Prasan Swatsitang, Paweena Wongphakham, Gulsiri Senawong. Cytotoxic effects of Thai noni juice product ethanolic extracts against cholangiocarcinoma cell lines. Asian Pacific Journal of Tropical Biomedicine 2021; 11(8) doi: 10.4103/2221-1691.319570
|
| 38 |
Malinee Thanee, Sureerat Padthaisong, Manida Suksawat, Hasaya Dokduang, Jutarop Phetcharaburanin, Poramate Klanrit, Attapol Titapun, Nisana Namwat, Arporn Wangwiwatsin, Prakasit Sa-ngiamwibool, Narong Khuntikeo, Hideyuki Saya, Watcharin Loilome. Sulfasalazine modifies metabolic profiles and enhances cisplatin chemosensitivity on cholangiocarcinoma cells in in vitro and in vivo models. Cancer & Metabolism 2021; 9(1) doi: 10.1186/s40170-021-00249-6
|
| 39 |
Jose Marin, Maria Monte, Rocio Macias, Marta Romero, Elisa Herraez, Maitane Asensio, Sara Ortiz-Rivero, Candela Cives-Losada, Silvia Di Giacomo, Javier Gonzalez-Gallego, Jose Mauriz, Thomas Efferth, Oscar Briz. Expression of Chemoresistance-Associated ABC Proteins in Hepatobiliary, Pancreatic and Gastrointestinal Cancers. Cancers 2022; 14(14) doi: 10.3390/cancers14143524
|
| 40 |
Chariya Hahnvajanawong, Supaluk Ketnimit, Kovit Pattanapanyasat, Natthinee Anantachoke, Banchob Sripa, Khosit Pinmai, Wunchana Seubwai, Vichai Reutrakul. Involvement of p53 and Nuclear Factor-kappaB Signaling Pathway for the Induction of G1-Phase Cell Cycle Arrest of Cholangiocarcinoma Cell Lines by Isomorellin. Biological and Pharmaceutical Bulletin 2012; 35(11) doi: 10.1248/bpb.b12-00118
|
| 41 |
Qian-Xi Fan, Yi-Rong Jiang, Jian-Bo Chen, Yi-Xue Chen, Qin-Qin Xu, Jie Wu, Hui-Feng Wang, Yi Yang, Jian-Zhang Pan, Qun Fang. Integrated Single-Cell Proteomic and Morphometric Analysis Reveals Heterogeneous Drug-Resistant Subpopulations. Analytical Chemistry 2025; 97(28) doi: 10.1021/acs.analchem.5c00809
|
| 42 |
Abdulkadir Isidan, Ali Yenigun, Daiki Soma, Eric Aksu, Kevin Lopez, Yujin Park, Arthur Cross-Najafi, Ping Li, Debjyoti Kundu, Michael G. House, Sanjukta Chakraborty, Shannon Glaser, Lindsey Kennedy, Heather Francis, Wenjun Zhang, Gianfranco Alpini, Burcin Ekser. Development and Characterization of Human Primary Cholangiocarcinoma Cell Lines. The American Journal of Pathology 2022; 192(9) doi: 10.1016/j.ajpath.2022.05.007
|
| 43 |
Jing Zhang, Ka-Yun Ng, Paul C. Ho. Interaction of Oxazaphosphorines with Multidrug Resistance-Associated Protein 4 (MRP4). The AAPS Journal 2010; 12(3) doi: 10.1208/s12248-010-9189-x
|
| 44 |
Leonardo Baiocchi, Keisaku Sato, Burcin Ekser, Lindsey Kennedy, Heather Francis, Ludovica Ceci, Ilaria Lenci, Domenico Alvaro, Antonio Franchitto, Paolo Onori, Eugenio Gaudio, Chaodong Wu, Sanjukta Chakraborty, Shannon Glaser, Gianfranco Alpini. Cholangiocarcinoma: bridging the translational gap from preclinical to clinical development and implications for future therapy. Expert Opinion on Investigational Drugs 2021; 30(4) doi: 10.1080/13543784.2021.1854725
|
| 45 |
Masaaki Nishi, Mitsuo Shimada, Tohru Utsunomiya, Yuji Morine, Satoru Imura, Tetsuya Ikemoto, Hiroki Mori, Jun Hanaoka, Yoshimi Bando. Role of dihydropyrimidine dehydrogenase and thymidylate synthase expression in immunohistochemistry of intrahepatic cholangiocarcinoma. Hepatology Research 2011; 41(1) doi: 10.1111/j.1872-034X.2010.00722.x
|
| 46 |
Kazuaki Nakamura, Kazuhiko Nakabayashi, Kyaw Htet Aung, Kazuko Aizawa, Naoko Hori, Junji Yamauchi, Kenichiro Hata, Akito Tanoue, Diego Calvisi. DNA Methyltransferase Inhibitor Zebularine Induces Human Cholangiocarcinoma Cell Death through Alteration of DNA Methylation Status. PLOS ONE 2015; 10(3) doi: 10.1371/journal.pone.0120545
|
| 47 |
Daniel Neureiter, Christian Mayr, Tobias Kiesslich. How do we choose the appropriate chemotherapeutic agents for biliary tract cancer?. Expert Opinion on Pharmacotherapy 2020; 21(3) doi: 10.1080/14656566.2019.1705280
|
| 48 |
Kittiya Islam, Parichut Thummarati, Pakkanun Kaewkong, Banchob Sripa, Tuangporn Suthiphongchai. Role of laminin and cognate receptors in cholangiocarcinoma cell migration. Cell Adhesion & Migration 2021; 15(1) doi: 10.1080/19336918.2021.1924422
|
| 49 |
Sopit Wongkham, Mutita Junking, Chaisiri Wongkham, Banchob Sripa, Siri Chur‐in, Norie Araki. Suppression of galectin‐3 expression enhances apoptosis and chemosensitivity in liver fluke‐associated cholangiocarcinoma. Cancer Science 2009; 100(11) doi: 10.1111/j.1349-7006.2009.01304.x
|
| 50 |
Jesus M. Banales, Vincenzo Cardinale, Guido Carpino, Marco Marzioni, Jesper B. Andersen, Pietro Invernizzi, Guro E. Lind, Trine Folseraas, Stuart J. Forbes, Laura Fouassier, Andreas Geier, Diego F. Calvisi, Joachim C. Mertens, Michael Trauner, Antonio Benedetti, Luca Maroni, Javier Vaquero, Rocio I. R. Macias, Chiara Raggi, Maria J. Perugorria, Eugenio Gaudio, Kirsten M. Boberg, Jose J. G. Marin, Domenico Alvaro. Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA). Nature Reviews Gastroenterology & Hepatology 2016; 13(5) doi: 10.1038/nrgastro.2016.51
|
| 51 |
Chutipa Chiawpanit, Methi Wathikthinnakorn, Nunghathai Sawasdee, Nattaporn Phanthaphol, Jatuporn Sujjitjoon, Mutita Junking, Montarop Yamabhai, Jutatip Panaampon, Pa-thai Yenchitsomanus, Aussara Panya. Precision immunotherapy for cholangiocarcinoma: Pioneering the use of human-derived anti-cMET single chain variable fragment in anti-cMET chimeric antigen receptor (CAR) NK cells. International Immunopharmacology 2024; 136 doi: 10.1016/j.intimp.2024.112273
|
| 52 |
Ubonrat Thamrongwaranggoon, Wunchana Seubwai, Chatchai Phoomak, Sakkarn Sangkhamanon, Ubon Cha'on, Thidarat Boonmars, Sopit Wongkham. Targeting hexokinase II as a possible therapy for cholangiocarcinoma. Biochemical and Biophysical Research Communications 2017; 484(2) doi: 10.1016/j.bbrc.2017.01.139
|
| 53 |
Rocio I.R. Macias, Jesus M. Banales, Bruno Sangro, Jordi Muntané, Matias A. Avila, Elisa Lozano, Maria J. Perugorria, Francisco J. Padillo, Luis Bujanda, Jose J.G. Marin. The search for novel diagnostic and prognostic biomarkers in cholangiocarcinoma. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2018; 1864(4) doi: 10.1016/j.bbadis.2017.08.002
|
| 54 |
Inthuon Kulma, Wanna Chaijaroenkul, Kesara Na Bangchang. Synergistic Effects of Atractylodes-Derived Sesquiterpenes and Polyacetylene on Chemotherapeutic Sensitivity in Cholangiocarcinoma: Impact on Transporter Gene Expression. Molecules 2026; 31(7) doi: 10.3390/molecules31071124
|
| 55 |
Suphannee Thanyaphoo, Chanachai Sae-Lee, Wilasinee Thaopech, Warisa Amornrit, Mutita Junking, Pa-thai Yenchitsomanus, Naravat Poungvarin, Adeel Sattar. Transcriptome insights into newcastle disease virus-mediated eradication of cholangiocarcinoma cells. PLOS One 2025; 20(5) doi: 10.1371/journal.pone.0322307
|
| 56 |
Wongwarut Boonyanugomol, Chariya Chomvarin, Chariya Hahnvajanawong, Banchob Sripa, Maria Kaparakis-Liaskos, Richard L. Ferrero, Yoshio Yamaoka. Helicobacter pylori cag Pathogenicity Island (cagPAI) Involved in Bacterial Internalization and IL-8 Induced Responses via NOD1- and MyD88-Dependent Mechanisms in Human Biliary Epithelial Cells. PLoS ONE 2013; 8(10) doi: 10.1371/journal.pone.0077358
|
| 57 |
Panadda Yotsomnuk, Wanwisa Skolpap, Veerachai Thitapakorn. Release dynamics and toxicological analysis of astilbin from lauric acid/BSA-coated superparamagnetic iron oxide nanoparticles. Colloids and Surfaces B: Biointerfaces 2025; 252 doi: 10.1016/j.colsurfb.2025.114620
|
| 58 |
Vivek B Mathema, Wanna Chaijaroenkul, Kesara Na-Bangchang. Cytotoxic activity and molecular targets of atractylodin in cholangiocarcinoma cells. Journal of Pharmacy and Pharmacology 2019; 71(2) doi: 10.1111/jphp.13024
|
| 59 |
Laura Fouassier, Marco Marzioni, Marta B. Afonso, Steven Dooley, Kevin Gaston, Gianluigi Giannelli, Cecilia M. P. Rodrigues, Elisa Lozano, Serena Mancarella, Oreste Segatto, Javier Vaquero, Jose J. G. Marin, Cédric Coulouarn. Signalling networks in cholangiocarcinoma: Molecular pathogenesis, targeted therapies and drug resistance. Liver International 2019; 39(S1) doi: 10.1111/liv.14102
|
| 60 |
Tullayakorn Plengsuriyakarn, Vithoon Viyanant, Veerachai Eursitthichai, Smarn Tesana, Wanna Chaijaroenkul, Arunporn Itharat, Kesara Na-Bangchang. Cytotoxicity, Toxicity, and Anticancer Activity of Zingiber Officinale Roscoe Against Cholangiocarcinoma. Asian Pacific Journal of Cancer Prevention 2012; 13(9) doi: 10.7314/APJCP.2012.13.9.4597
|
| 61 |
Marta Alonso-Peña, Ricardo A Espinosa-Escudero, Meraris Soto-Muñiz, Paula Sanchon-Sanchez, Anabel Sanchez-Martin, Jose JG Marin. Role of Transportome in the Pharmacogenomics of Hepatocellular Carcinoma and Hepatobiliary Cancer. Pharmacogenomics 2019; 20(13) doi: 10.2217/pgs-2019-0033
|
| 62 |
Vivek B Mathema, Wanna Chaijaroenkul, Juntra Karbwang, Kesara Na‐Bangchang. Growth inhibitory effect of β‐eudesmol on cholangiocarcinoma cells and its potential suppressive effect on heme oxygenase‐1 production, STAT1/3 activation, and NF‐κB downregulation. Clinical and Experimental Pharmacology and Physiology 2017; 44(11) doi: 10.1111/1440-1681.12818
|
| 63 |
Kitti Intuyod, Paula Saavedra-García, Stefania Zona, Chun-Fui Lai, Yannasittha Jiramongkol, Kulthida Vaeteewoottacharn, Chawalit Pairojkul, Shang Yao, Jay-Sze Yong, Sasanan Trakansuebkul, Sakda Waraasawapati, Vor Luvira, Sopit Wongkham, Somchai Pinlaor, Eric W.-F. Lam. RETRACTED ARTICLE: FOXM1 modulates 5-fluorouracil sensitivity in cholangiocarcinoma through thymidylate synthase (TYMS): implications of FOXM1–TYMS axis uncoupling in 5-FU resistance. Cell Death & Disease 2018; 9(12) doi: 10.1038/s41419-018-1235-0
|
| 64 |
NICHAPAVEE NUTTHASIRIKUL, CHARIYA HAHNVAJANAWONG, ANCHALEE TECHASEN, TEMDUANG LIMPAIBOON, CHANVIT LEELAYUWAT, SIRI CHAU-IN, PATCHAREE JEARANAIKOON. Targeting the Δ133p53 isoform can restore chemosensitivity in 5-fluorouracil-resistant cholangiocarcinoma cells. International Journal of Oncology 2015; 47(6) doi: 10.3892/ijo.2015.3188
|
| 65 |
Maitane Asensio, Oscar Briz, Elisa Herraez, Laura Perez-Silva, Ricardo Espinosa-Escudero, Diego Bueno-Sacristan, Ana Peleteiro-Vigil, Helen Hammer, Oliver Pötz, Onat Kadioglu, Jesus M. Banales, Maria L. Martinez-Chantar, Matias A. Avila, Rocio I.R. Macias, Thomas Efferth, Jose J.G. Marin, Elisa Lozano. Sensitizing cholangiocarcinoma to chemotherapy by inhibition of the drug-export pump MRP3. Biomedicine & Pharmacotherapy 2024; 180 doi: 10.1016/j.biopha.2024.117533
|
| 66 |
Narintorn Rattanata, Sakda Daduang, Molin Wongwattanakul, Chanvit Leelayuwat, Temduang Limpaiboon, Ratsami Lekphrom, Alisa Sandee, Patcharee Boonsiri, Sirinart Chio-Srichan, Jureerut Daduang. Gold Nanoparticles Enhance the Anticancer Activity of Gallic Acid against Cholangiocarcinoma Cell Lines. Asian Pacific Journal of Cancer Prevention 2015; 16(16) doi: 10.7314/APJCP.2015.16.16.7143
|
| 67 |
Hiroaki Sugiyama, Kenichiro Onuki, Kazunori Ishige, Nobue Baba, Tetsuya Ueda, Sachiko Matsuda, Kaoru Takeuchi, Masafumi Onodera, Yasuni Nakanuma, Masayuki Yamato, Masakazu Yamamoto, Ichinosuke Hyodo, Junichi Shoda. Potent in vitro and in vivo antitumor activity of sorafenib against human intrahepatic cholangiocarcinoma cells. Journal of Gastroenterology 2011; 46(6) doi: 10.1007/s00535-011-0380-3
|
| 68 |
Dawoon E. Jung, Soo Been Park, Kahee Kim, Chanyang Kim, Si Young Song. CG200745, an HDAC inhibitor, induces anti-tumour effects in cholangiocarcinoma cell lines via miRNAs targeting the Hippo pathway. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-11094-3
|
| 69 |
Sarunya Kitdumrongthum, Somrudee Reabroi, Kanoknetr Suksen, Patoomratana Tuchinda, Bamroong Munyoo, Panupong Mahalapbutr, Thanyada Rungrotmongkol, Puey Ounjai, Arthit Chairoungdua. Inhibition of topoisomerase IIα and induction of DNA damage in cholangiocarcinoma cells by altholactone and its halogenated benzoate derivatives. Biomedicine & Pharmacotherapy 2020; 127 doi: 10.1016/j.biopha.2020.110149
|
| 70 |
Mingzhen Bai, Ruoshui Wang, Chongfei Huang, Ruyang Zhong, Ningzu Jiang, Wenkang Fu, Ningning Mi, Long Gao, Yuyao Jin, Haidong Ma, Jie Cao, Haiying Yu, Qiang Jing, Chao Zhang, Ping Yue, Yong Zhang, Yanyan Lin, Hengwei Zhang, Wenbo Meng. Biological and genetic characterization of a newly established human primary multidrug-resistant distal cholangiocarcinoma cell line, CBC3T-6. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-81392-0
|
| 71 |
Detlef Bartkowiak, Michael Stempfhuber, Thomas Wiegel, Dirk Bottke. Radiation- and Chemoinduced Multidrug Resistance in Colon Carcinoma Cells. Strahlentherapie und Onkologie 2009; 185(12) doi: 10.1007/s00066-009-1993-9
|
| 72 |
Benchamart Moolmuang, Jittiporn Chaisaingmongkol, Pattama Singhirunnusorn, Mathuros Ruchirawat. PLK1 inhibition leads to mitotic arrest and triggers apoptosis in cholangiocarcinoma cells. Oncology Letters 2024; 28(1) doi: 10.3892/ol.2024.14449
|
| 73 |
Banchob Sripa, Wunchana Seubwai, Kulthida Vaeteewoottacharn, Kanlayanee Sawanyawisuth, Atit Silsirivanit, Worasak Kaewkong, Kanha Muisuk, Paweena Dana, Chatchai Phoomak, Worachart Lert-itthiporn, Vor Luvira, Chawalit Pairojkul, Bin T. Teh, Sopit Wongkham, Seiji Okada, Yaovalux Chamgramol. Functional and genetic characterization of three cell lines derived from a single tumor of an Opisthorchis viverrini-associated cholangiocarcinoma patient. Human Cell 2020; 33(3) doi: 10.1007/s13577-020-00334-w
|
| 74 |
Annamaria Massa, Chiara Varamo, Francesca Vita, Simona Tavolari, Caterina Peraldo-Neia, Giovanni Brandi, Alessandro Rizzo, Giuliana Cavalloni, Massimo Aglietta. Evolution of the Experimental Models of Cholangiocarcinoma. Cancers 2020; 12(8) doi: 10.3390/cancers12082308
|
| 75 |
Hatice YILDIRIM, Ayşe Tuğşen AYDEMİR. Multidrug resistance gene expression response to cisplatin and 5FU treatment in hepatoma, prostate and colon cancer cells. Balıkesir Üniversitesi Fen Bilimleri Enstitüsü Dergisi 2020; 22(2) doi: 10.25092/baunfbed.757286
|
| 76 |
Jiaqi Yang, David Sontag, Yuewen Gong, Gerald Y Minuk. Enhanced gemcitabine cytotoxicity with knockdown of multidrug resistance protein genes in human cholangiocarcinoma cell lines. Journal of Gastroenterology and Hepatology 2021; 36(4) doi: 10.1111/jgh.15289
|
| 77 |
Sarunya Kitdumrongthum, Chanatip Metheetrairut, Varodom Charoensawan, Puey Ounjai, Keatdamrong Janpipatkul, Wittaya Panvongsa, Jittima Weerachayaphorn, Pawinee Piyachaturawat, Arthit Chairoungdua. Dysregulated microRNA expression profiles in cholangiocarcinoma cell-derived exosomes. Life Sciences 2018; 210 doi: 10.1016/j.lfs.2018.08.058
|
| 78 |
Saengrawee Thammawithan, Jirattiporn Thanuma, Sirinya Sitthirak, Chadapohn Panplu, Thapanee Pruksatrakul, Piya Prajumwongs, Arporn Wangwiwatsin, Poramate Klanrit, Watcharin Loilome, Nisana Namwat, Ghulam Yaseen. UHPLC-QTOF-MS/MS-based metabolomic discovery of anticancer compounds in ethanolic extracts of Ficus hispida L. f.. PLOS One 2026; 21(3) doi: 10.1371/journal.pone.0343411
|
| 79 |
Pornpattra Rattanaseth, Kanlaya Katewongsa, Kitti Intuyod, Somchai Pinlaor, Raynoo Thanan, Chadamas Sakonsinsiri. Poly(d,l-lactide-co-glycolide) Nanoparticles Encapsulating Doxorubicin for Improved Treatment in Cholangiocarcinoma and Drug-Resistant Cells. ACS Applied Bio Materials 2025; 8(7) doi: 10.1021/acsabm.5c00628
|